A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

Recruiting

Phase 3

A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior UveitisA Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

Sponsor:

Priovant Therapeutics, Inc.

Code:

NCT06431373

Conditions

Uveitis, Posterior

Uveitis, Intermediate

Uveitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Brepocitinib PO QD

Placebo PO QD

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Priovant Therapeutics, Inc. on 2024-11-27.